Clinical Trial Update: US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation [Phase 1]

View source ↗

Summary

Phase 1 US trial evaluating an initial formulation for bronchoscopic lung volume reduction in emphysema has completed its study (status: COMPLETED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Emphysema

Snippet

Sponsor: Aeris Therapeutics | Conditions: Pulmonary Emphysema | Phase 1 | Status: COMPLETED